glp 1 inflammatory bowel disease A surprising role for enteroendocrine cells and GLP-1 in regulating intestinal inflammation Glucagon-like peptide 1 receptor (GLP-1R)

What did the studies find

assimilable by intestinal cells

In some embodiments, the otic pharmaceutical formulation comprises about 71% by weight of the triglycerides

45 Additional studies confirmed that N-AcGIP, another long-acting GIP agonist, 46 decreased osteoclast-mediated bone resorption and enhanced cortical bone quality in rodents

Similar content being viewed by others Introduction Type 2 diabetes mellitus (T2D), commonly linked with obesity, is a chronic metabolic disease characterized by insulin resistance and progressive failure of pancreatic -cells to meet the insulin secretory demand, resulting in poor glycaemic control associated with a multitude of co-morbidities, including metabolic dysfunction-associated steatotic liver disease (MASLD) 1,2 , diabetic kidney disease 3,4 , and cardiovascular dysfunction 5